Agree Buckeyes. If they can secure financing for BoM2 and establish firm/ concrete timelines then the sp should respond very favourably. Given that I think it could go back to the $2 range and even more as the trial progresses. They can keep working the Covid angle but I always believed that the real payoff is with the mainstream program.